Smoking is associated with renal impairment and proteinuria in the normal population: The AusDiab kidney study

American Journal of Kidney Diseases

Volumn 40, Issue 4, 2002, Pages 704-712

  Briganti, Esther M ^a,b,c,d   Branley, Pauline ^a,b,c,d   Chadban, Steven J ^a,b,c,d   Shaw, Jonathan E ^a,b,c,d   McNeil, John J ^a,b,c,d   Welborn, Timothy A ^a,b,c,d   Atkins, Robert C ^a,b,c,d  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c International Diabetes Institute   (Canada)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Epidemiology; Population; Proteinuria; Renal impairment; Smoking; Survey

Indexed keywords

CREATININE; GLUCOSE; PROTEIN;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; MALE; POPULATION RESEARCH; PROTEIN URINE LEVEL; PROTEINURIA; QUESTIONNAIRE; RISK FACTOR; SMOKING;

EID: 0036788391     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.35677     Document Type: Article

References (59)

1. Orth SR, Stockmann A, Conradt C, et al: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54:926-931, 1998
2. Stengel B, Couchoud C, Cenee S, Hemon D: Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 57:2519-2526, 2000
3. Christiansen JS: Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1:146-149, 1978
4. Norden G, Nyberg G: Smoking and diabetic nephropathy. Acta Med Scand 215:257-261, 1984
5. Telmer S, Christiansen JS, Andersen AR, Nerup J, Deckert T: Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215:63-68, 1984
6. Mackin P, Macleod JM, New JP, Marshall SM: Renal function in long-duration type I diabetes. Diabetes Care 19:249-251, 1996
7. Bruno G, Cavallo-Perin P, Bargero G, et al: Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 19:43-47, 1996
8. Ikeda Y, Suehiro T, Takamatsu K, Yamashita H, Tamura T, Hashimoto K: Effect of smoking on the prevalence of albuminuria in Japanese men with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract Suppl 36:57-61, 1997
9. Gambaro G, Bax G, Fusaro M, et al: Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. Diabetes Nutr Metab 14:337-342, 2001
10. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1349-1354, 1994
11. Klein R, Klein BE, Moss SE: Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 42:381-389, 1993
12. Muhlhauser I, Overmann H, Bender R, Jorgens V, Berger M: Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy. Diabet Med 17:727-734, 2000
13. Colhoun HM, Lee ET, Bennett PH, et al: Risk factors for renal failure: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44:S46-S53, 2001 (suppl 2)
14. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
15. Goetz FC, Jacobs DR Jr, Chavers B, Roel J, Yelle M, Sprafka JM: Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol 145:91-102, 1997
16. Chuahirun T, Wesson DE: Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 39:376-382, 2002
17. Regalado M, Yang S, Wesson DE: Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35:687-694, 2000
18. Ward MM, Studenski S: Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152:2082-2088, 1992
19. Dales LG, Friedman GD, Siegelaub AB, Seltzer CC, Ury HK: Cigarette smoking habits and urine characteristics: Urinalysis abnormalities are more common in smokers, but the reasons are unclear. Nephron 20:167-170, 1978
20. Perry HM Jr, Miller JP, Fornoff JR, et al: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25:587-594, 1995
21. Whelton PK, Randall B, Neaton J, Stamler J, Brancati FL, Klag MJ: Cigarette smoking and ESRD incidence in men screened for the MRFIT. J Am Soc Nephrol 6:408A, 1995 (abstr)
22. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG: Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 57:2072-2079, 2000
23. Halimi JM, Giraudeau B, Vol S, et al: Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 58:1285-1292, 2000
24. Gerstein HC, Mann JF, Pogue J, et al: Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 23:B35-B39, 2000
25. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE: Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133:585-591, 2000
26. Wingard DL, Barrett-Connor EL, Scheidt-Nave C, McPhillips JB: Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. A population-based study. Diabetes Care 16:1022-1025, 1993
27. Nelson RG, Bennett PH, Beck GJ, et al: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335:1636-1642, 1996
28. Gabir MM, Hanson RL, Dabelea D, et al: Plasma glucose and prediction of microvascular disease and mortality: Evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23:1113-1118, 2000
29. Ribstein J, Du Cailar G, Mimran A: Glucose tolerance and age-associated decline in renal function of hypertensive patients. J Hypertens 19:2257-2264, 2001
30. Dunstan DW, Zimmet PZ, Welborn TA, et al: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-Methods and response rates. Diabetes Res Clin Pract 57:119-129, 2002
31. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
32. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17:863-871, 1916
33. Ginsberg JM, Chang BS, Matarese RA, Garella S: Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543-1546, 1983
34. Ruggenenti P, Gaspari F, Perna A, Remuzzi G: Cross sectional longitudinal study of spot morning urine protein: creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ 316:504-509, 1998
35. Anonymous: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland, World Health Organization, 1999
36. Wheeler DC: Lipids- What is the evidence for their role in progressive renal disease? Nephrol Dial Transplant 10:14-16, 1995
37. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 26:610-615, 1995
38. Wanner C, Quaschning T: Dyslipidemia and renal disease: Pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens 10:195-201, 2001
39. Wheeler DC, Persaud JW, Fernando R, Sweny P, Varghese Z, Moorhead JF: Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. Nephrol Dial Transplant 5:185-191, 1990
40. Chana RS, Wheeler DC, Thomas GJ, Williams JD, Davies M: Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis. Nephrol Dial Transplant 15:167-172, 2000
41. Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis 16:236-243, 1990
42. Nguyen HT, Shannon AG, Coates PA, Owens DR: Estimation of glomerular filtration rate in type II (non-insulin dependent) diabetes mellitus patients. IMA J Math Appl Med Biol 14:151-160, 1997
43. Friedman JR, Norman DC, Yoshikawa TT: Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. J Am Geriatr Soc 37:145-149, 1989
44. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39:S46-S75, 2002 (suppl 1)
45. Hsu CY, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 61:1567-1576, 2002
46. Hill AB: The environment and disease: Association or cause? Proc R Soc Med 58:295-300, 1965
47. Black HR, Zeevi GR, Silten RM, Walker Smith GJ: Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 34:173-179, 1983
48. Nicholson JP, Teichman SL, Alderman MH, Sos TA, Pickering TG, Laragh JH: Cigarette smoking and renovascular hypertension. Lancet 2:765-766, 1983
49. Black HR, Cooper KA: Cigarette smoking and atherosclerotic renal artery stenosis. J Clin Hypertens 2:322-330, 1986
50. Svetkey LP, Kadir S, Dunnick NR, et al: Similar prevalence of renovascular hypertension in selected blacks and whites. Hypertension 17:678-683, 1991
51. Appel RG, Bleyer AJ, Reavis S, Hansen KJ: Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 48:171-176, 1995
52. Cryer PE, Haymond MW, Santiago JV, Shah SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295:573-577, 1976
53. Halimi JM, Philippon C, Mimran A: Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant 13:940-944, 1998
54. Ritz E, Benck U, Franek E, Keller C, Seyfarth M, Clorius J: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9:1798-1804, 1998
55. Benck U, Clorius JH, Zuna I, Ritz E: Renal hemodynamic changes during smoking: Effects of adrenoreceptor blockade. Eur J Clin Invest 29:1010-1018, 1999
56. Blache D, Bouthillier D, Davignon J: Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis 93:179-188, 1992
57. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 70:707-711, 1993
58. Celermajer DS, Sorensen KE, Georgakopoulos D, et al: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149-2155, 1993
59. Celermajer DS, Adams MR, Clarkson P, et al: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334:150-154, 1996